149 related articles for article (PubMed ID: 24121179)
1. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
3. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients.
Guerry P; Erlandson RA; Rosen PP
Cancer; 1988 Apr; 61(8):1611-20. PubMed ID: 2832048
[TBL] [Abstract][Full Text] [Related]
4. Invasive cystic hypersecretory carcinoma of the breast: a case report.
Lee JS; Lee YJ
J Korean Med Sci; 2004 Feb; 19(1):149-51. PubMed ID: 14966360
[TBL] [Abstract][Full Text] [Related]
5. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
6. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.
Kawaguchi K; Shin SJ
Am J Surg Pathol; 2012 Jul; 36(7):1009-20. PubMed ID: 22446941
[TBL] [Abstract][Full Text] [Related]
8. Invasive cystic hypersecretory carcinoma of the breast: a case report.
Liu J; Yang W; Wu X; Hu X
Int J Clin Exp Pathol; 2015; 8(6):7499-502. PubMed ID: 26261660
[TBL] [Abstract][Full Text] [Related]
9. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
[TBL] [Abstract][Full Text] [Related]
10. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature.
Sun J; Wang X; Wang C
BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638
[TBL] [Abstract][Full Text] [Related]
11. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma arising from preexisting pregnancy-like and cystic hypersecretory hyperplasia lesions of the breast: a clinicopathologic study of 9 patients.
Shin SJ; Rosen PP
Am J Surg Pathol; 2004 Jun; 28(6):789-93. PubMed ID: 15166671
[TBL] [Abstract][Full Text] [Related]
14. Identification of a basal-like subtype of breast ductal carcinoma in situ.
Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
[TBL] [Abstract][Full Text] [Related]
16. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
Fadare O; Wang SA; Hileeto D
Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.
VandenBussche CJ; Elwood H; Cimino-Mathews A; Bittar Z; Illei PB; Warzecha HN
Hum Pathol; 2013 Nov; 44(11):2487-93. PubMed ID: 24029706
[TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ-like structures in metastatic breast carcinoma.
Kordek R
Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.
Thike AA; Iqbal J; Cheok PY; Tse GM; Tan PH
J Clin Pathol; 2013 Aug; 66(8):665-70. PubMed ID: 23539741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]